![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Status of Truvada (TVD) for HIV Pre-Exposure Prophylaxis (PrEP) in the United States:
An Early Drug Utilization Analysis
|
|
|
ICAAC 2013 Sept 10-13 Denver Colrado
RM Mera, MK Rawlings, A Pechonkina, JF Rooney, T Peschel, A Cheng
Gilead Sciences, Inc., Foster City, CA
![ICAAC1.gif](../images/091213/091213-6/ICAAC1.gif)
![ICAAC2.gif](../images/091213/091213-6/ICAAC2.gif)
![ICAAC3.gif](../images/091213/091213-6/ICAAC3.gif)
![ICAAC4.gif](../images/091213/091213-6/ICAAC4.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|